Self-management of medical abortion: a qualitative evidence synthesis

References

• E. Chong, L.J. Frye, J. Castle. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S. Contraception. 92(3): 2015; 215–219.
   Web of Science ®Google Scholar
• K. Iyengar, M. Klingberg-Allvin, S.D. Iyengar. Home use of misoprostol for early medical abortion in a low resource setting: secondary analysis of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica. 95: 2016; 173–181.
   Web of Science ®Google Scholar
• E.G. Raymond, D. Grossman, E. Wiebe. Reaching women where they are: eliminating the initial in-person medical abortion visit. Contraception. 92(3): 2015; 190–193.
   Web of Science ®Google Scholar
• P.A. Lohr, J. Wade, L. Riley. Women's opinions on the home management of early medical abortion in the UK. The Journal of Family Planning and Reproductive Health Care. 36(1): 2010; 21–25.
   Google Scholar
• S. Cameron, A. Glasier, H. Dewart. Women’s experiences of the final stage of early medical abortion at home: results of a pilot survey. The Journal of Family Planning and Reproductive Health Care. 36(4): 2010; 213–216.
   Google Scholar
• K.S. Louie, E. Chong, T. Tsereteli. The introduction of first trimester medical abortion in Armenia. Reproductive Health Matters. 22(44 Suppl.1): 2015; 56–66.
   Web of Science ®Google Scholar
• A. Shrestha, L.B. Sedhai. A randomized trial of hospital vs home self-administration of vaginal misoprostol for medical abortion. Kathmandu University Medical Journal. 12(47): 2014; 185–189.
   Google Scholar
• D. Constant, K. de Tolly, J. Harries. Assessment of completion of early medical abortion using a text questionnaire on mobile phones compared to a self-administered paper questionnaire among women attending four clinics, Cape Town, South Africa. Reproductive Health Matters. 22(44 Suppl 1): 2015; 83–93.
   Web of Science ®Google Scholar
• M. Puri, S. Regmi, A. Tamang. Road map to scaling-up: translating operations research study’s results into actions for expanding medical abortion services in rural health facilities in Nepal. Health Research, Policy and Systems. 12(24): 2014; 1–7.
   Google Scholar
• N.S. Whaley, A.E. Burke. Update on medical abortion: simplifying the process for women. Current Opinion in Obstetrics and Gynecology. 27(6): 2015; 476–481.
   Web of Science ®Google Scholar
• World Health Organization. Safe abortion: technical and policy guidance for health systems [Internet]. WHO. http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434_eng.pdf
   Google Scholar
• World Health Organization. Health worker roles in providing safe abortion care and post abortion contraception [Internet]. http://apps.who.int/iris/bitstream/10665/181041/1/9789241549264_eng.pdf?ua=1&ua=1. 2015
   Google Scholar
• C.J. Colvin, J. de Heer, L. Winterton. A systematic review of qualitative evidence on barriers and facilitators to the implementation of task-shifting in midwifery services. Midwifery. 29(10): 2015; 1211–1221.
   Web of Science ®Google Scholar
• S. Lewin, C. Glenton, H. Munthe-Kaas. Using qualitative evidence in decision making for health and social interventions: An approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Medicine. 2015
   Google Scholar
• J. Noyes, S. Lewin, J. Noyes. Chapter 6: Supplemental Guidance on Selecting a Method of Qualitative Evidence Synthesis, and Integrating Qualitative Evidence with Cochrane Intervention Reviews. Supplementary Guidance for Inclusion of Qualitative Research in Cochrane Systematic Reviews of Interventions. Version 1 (updated August 2011): Cochrane Collaboration Qualitative Methods Group. 2011
   Google Scholar
• C. Ellertson, W. Simonds, B. Winikoff. Providing mifepristone-misoprostol medical abortion: The view from the clinic. Journal of the American Medical Women's Association. 54(2): 1999. 91-6 (+ 102).
   Google Scholar
• W. Simonds, C. Ellertson, K. Springer. Abortion, revised: Participants in the U.S. clinical trials evaluate mifepristone. Social Science and Medicine. 46(10): 1998; 1313–1323.
   PubMed Web of Science ®Google Scholar
• R. Acharya, S. Kalyanwala. Knowledge, attitudes, and practices of certified providers of medical abortion: Evidence from Bihar and Maharashtra, India. International Journal of Gynaecology and Obstetrics. 118: 2012; S40–S46.
   Web of Science ®Google Scholar
• A. Alam, H. Bracken, H.B. Johnston. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. International Perspectives on Sexual and Reproductive Health. 39(2): 2013; 79–87.
   Web of Science ®Google Scholar
• B. Ganatra, S. Kalyanwala, B. Elul. Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics. Global Public Health. 5(4): 2010; 335–347.
   Web of Science ®Google Scholar
• B. Elul, E. Pearlman, A. Sorhaindo. In-depth interviews with medical abortion clients: Thoughts on the method and home administration of misoprostol. Journal of the American Medical Women's Association. 55(3): 2000; 169–172.
   Google Scholar
• S.L. Fielding, E. Edmunds, E.A. Schaff. Having an abortion using mifepristone and home misoprostol: A qualitative analysis of women's experiences. Perspectives on Sexual and Reproductive Health. 34(1): 2002; 34–40.
   PubMed Web of Science ®Google Scholar
• A. Kero, M. Wulff, A. Lalos. Home abortion implies radical changes for women. The European Journal of Contraception & Reproductive Health Care. 14(5): 2009; 324–333.
   PubMed Web of Science ®Google Scholar
• A. Kero, A. Lalos, M. Wulff. Home abortion – experiences of male involvement. The European Journal of Contraception & Reproductive Health Care. 15: 2010; 264–270.
   PubMed Web of Science ®Google Scholar
• K. Grindlay, K. Lane, D. Grossman. Women's and providers' experiences with medical abortion provided through telemedicine: A qualitative study. Women's Health Issues. 23(2): 2013; e117–e122.
   Web of Science ®Google Scholar
• M. Makenzius, T. Tyden, E. Darj. Autonomy and dependence – experiences of home abortion, contraception and prevention. Scandinavian Journal of Caring Sciences. 27: 2012; 569–579.
   Web of Science ®Google Scholar
• P.H. Petitet, L. Ith, M. Cockroft. Towards safe abortion access: an exploratory study of medical abortion in Cambodia. Reproductive Health Matters. Suppl(44)(55): 2015; 47.
   Google Scholar
• B. Ganatra, M. Vinoj, P.S. Prasad. Medical abortion in Bihar and Jharkhand. 2005; IPAS: New Delhi, India.
   Google Scholar
• E.M.H. Mitchell, A. Kwizera, M. Usta. Choosing early pregnancy termination methods in Urban Mozambique. Social Science & Medicine. 71: 2010; 62–70.
   Web of Science ®Google Scholar
• P. Nanda, A. Barva, S. Dalvie. Exploring the transformative potential of medical abortion for women in India. 2010; International Center for Research on Women: New Delhi, India.
   Google Scholar
• H. Espinoza, K. Abuabara, C. Ellertson. Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. Contraception. 70: 2004; 127–133.
   Web of Science ®Google Scholar
• G. Pheterson, Y. Azize. Abortion practice in the Northeast Caribbean: “Just write down stomach pain”. Reproductive Health Matters. 13(26): 2005; 44–53.
   PubMed Web of Science ®Google Scholar
• J. Cohen, O. Ortiz, S.E. Llaguno. Reaching women with instructions on misoprostol use in a Latin American country. Reproductive Health Matters. 13(26): 2005; 84–92.
   PubMed Web of Science ®Google Scholar
• V. Fiol, L. Briozzo, A. Labandera. Improving care of women at risk of unsafe abortion: Implementing a risk-reduction model at the Uruguayan-Brazilian border. International Journal of Gynaecology and Obstetrics. 118: 2012. S21-S27.
   Web of Science ®Google Scholar
• M.K. Nations, C. Misago, W. Fonseca. Women's hidden transcripts about abortion in Brazil. Social Science and Medicine. 44(12): 1997; 1833–1845.
   PubMed Web of Science ®Google Scholar
• J. Sherris, A. Bingham, M.A. Burns. Misoprostol use in developing countries: Results from a multicountry study. International Journal of Gynaecology and Obstetrics. 88: 2005; 76–81.
   PubMed Web of Science ®Google Scholar
• M.M. Arilha. Misoprostol: percursos, mediacoes e redes sociais para o acesso ao aborto medicamentoso em contextos de ilegalidade no Estado de Sao Paulo. Ciência & Saúde Coletiva. 17(7): 2012; 1785–1794.
   Web of Science ®Google Scholar
• L. Bury, S.A. Bruch, X.M. Barbery. Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia. International Journal of Gynaecology and Obstetrics. 118: 2012; S4–S9.
   Web of Science ®Google Scholar
• D. Grossman, K. Holt, M. Pena. Self-induction of abortion among women in the United States. Reproductive Health Matters. 18(36): 2010; 136–146.
   PubMed Web of Science ®Google Scholar
• R.I. Drovetta. Safe abortion information hotlines: an effective strategy for increasing women's access to safe abortions in Latin America. Reproductive Health Matters. 23(45): 2015; 47–57.
   PubMed Web of Science ®Google Scholar
• J.D. Gipson, A.E. Hirz, J.L. Avila. Perceptions and practices of illegal abortion among urban young adults in the Philippines: A qualitative study. Studies in Family Planning. 42(4): 2011; 261–272.
   Web of Science ®Google Scholar
• B. Subha Sri, T.K. Sundari Ravindran. Medical abortion: Understanding perspectives of rural and marginalized women from rural South India. International Journal of Gynaecology and Obstetrics. 118: 2012; S33–S39.
   Google Scholar
• S.M. Harvey, L.J. Beckman, M.R. Branch. The relationship of contextual factors to women's perceptions of medical abortion. Health Care for Women International. 23: 2002; 654–665.
   PubMedGoogle Scholar
• S. Ramos, M. Romero, L. Aizenberg. Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina. Reproductive Health Matters. Suppl(43): 2015; 1–12.
   Google Scholar
• R.M. Barbosa, M. Arilha. A experencia brasileira com o cytotec. Estudos Feministas. 2(93): 1993; 408–417.
   Google Scholar
• R.M. Barbosa, M. Arilha. The Brazilian experience with Cytotec. Studies in Family Planning. 24(4): 1993; 236–240.
   PubMed Web of Science ®Google Scholar
• D. Diniz, A. Madeiro. Cytotec e aborto: A policia, os vendedores e as mulheres. Ciência & Saúde Coletiva. 17(7): 2012; 1795–1804.
   Web of Science ®Google Scholar
• Z.C. Silva do Nascimento Souza, N.M. Freire Diniz, T. Menezes Couto. Trajectoria de mulheres em situacao de aborto provocado no discurso sobre clandestinidade. Acta Paulista de Enfermagem. 23(6): 2010; 732–736.
   Web of Science ®Google Scholar
• L.M. Vallely, P. Homiehombo, A. Kelly-Hanku. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea – a descriptive study of women's and health care workers' experiences. Reproductive Health. 12(22): 2015; 1–11.
   Google Scholar
• D. Grossman. Evaluation of a harm-reduction model of service delivery for women with unintended pregnancies in Peru. 2013; Ibis Reproductive Health: Oakland, CA, USA.
   Google Scholar
• Bpas. Clinical Guidelines: Early Medical Abortion. 2015; Bpas: Warwickshire, UK.
   Google Scholar
• M. Gold, E. Chong. If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion. Contraception. 92(3): 2015; 194–196.
   Web of Science ®Google Scholar
• D. Grossman, P. Goldstone. Mifepristone by prescription: a dream in the United States but reality in Australia. Contraception. 92(3): 2015; 186–189.
   Web of Science ®Google Scholar